Elan sells Botox rival Myobloc to Solstice

- Last updated on GMT

Related tags: Botulinum toxin

Irish neuroscience based biopharmaceuticals company Elan has sold
its botulinum toxin type B product Myobloc/Neurobloc to Solstice
Neurosciences for up to €15 million.

Elan​ has announced the sale of its worldwide rights to Myobloc/Neurobloc, a botulinum toxin type B to Solstice Neurosciences, a newly formed company focused on the development, manufacturing, sales and marketing of speciality biopharmaceutical products.

Included in the sale are the related intellectual property, the product inventory, and the manufacturing facility. The associated manufacturing employees will be offered the opportunity to continue their work with Myobloc as employees of Solstice.

Myobloc was developed by Elan and is currently approved in the US, Canada and Europe for the treatment of cervical dystonia to reduce the severity of abnormal head position and neck pain.

Perhaps the most commonly known use of botulinum toxin is as an anti-wrinkle treatment. However, Myobloc has faced stiff competition from established rival Botox.

Related topics: Business & Financial, Skin Care

Related news

Related products

show more

Postbiotics linked to improved Skin Health

Postbiotics linked to improved Skin Health

Mitsubishi Corporation Life Science Europe | 09-Nov-2022 | Product Presentation

L-137™ is a heat-treated strain of Lactobacillus plantarum; this Postbiotic ingredient has the unique capability of improving Skin Health from within.

Let’s enjoy the great outdoors again, safely

Let’s enjoy the great outdoors again, safely

Lipotec | 14-Oct-2022 | Product Presentation

Lubrizol Xpozuki™ biotech ingredient is on a mission to support the restoration of 1 million hectares of trees throughout the Andes. With every km you...

Green Cosmetics Analytical report 

Green Cosmetics Analytical report 

PatSnap | 06-Oct-2022 | Technical / White Paper

Green cosmetics are a growing sub-market within the skin care industry and signs point to it only growing in strength.

Related suppliers

Follow us


View more